[CAS NO. 2319587-80-7]  Vimentin-IN-1

Ships within Stock Price Qty Total
$0.00
$0.00
Please click "REQUEST A QUOTE" button if you need other sizes or custom synthesis
request a quote
If there is no stock, or you need other sizes or custom synthesis, please:

PRODUCTS SPECIFICATIONS [2319587-80-7]

Catalog
HY-151424
Brand
MCE
CAS
2319587-80-7

DESCRIPTION [2319587-80-7]

Overview

MDL-
Molecular Weight389.28
Molecular FormulaC19H18Cl2N4O
SMILESCOC1=CC(Cl)=CC(N2CCN(C3=C4C=CC=C(Cl)C4=NN=C3)CC2)=C1

For research use only. We do not sell to patients.

Summary

Vimentin-IN-1 is a FiVe1 derivative, an orally active and selective anticancer agent. FiVe1 binds type III intermediate filament protein vimentin ( VIM ), to induce hyperphosphorylation of Ser56, resulting selective disruption of mitosis and multinucleation in transformed VIM-expressing mesenchymal cancer cells. Vimentin-IN-1 shows better oral bioavailability and pharmacokinetic profiles than FiVe1 [1] .


IC50 & Target

vimentin (VIM) [1]


In Vitro

Vimentin-IN-1 (compound 4e) (0-10 mM; 72 h) inhibits a marked improvement in potency with an IC 50 value of 44 nM against HT-1080 fibrosarcoma, better than than FiVe1 (IC 50 =1.6 μM, HT-1080) [1] .
Vimentin-IN-1 (0.1 μM; 24 h) induces phosphorylation of VIM at Ser56 [1] .
Vimentin-IN-1 (100 μM; sampled at 0, 5, 15, 30, 45, and 60 min) exhibits poor stability with 0.0% remaining after 60 min of incubation in mouse liver microsome [1] .

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Viability Assay [1]

Cell Line: HT-1080, RD, and MCF-7 cells
Concentration: 0-10 mM
Incubation Time: 72 hours
Result: Inhibited HT-1080, RD, and MCF-7 cells with IC 50 s of 44 nM, 61 nM, and 49 nM, respectively.

In Vivo

Vimentin-IN-1 (compound 4e) (10 mg/kg; p.o.; single dose) shows better oral pharmacokinetic properties than Five1 [1] .
Pharmacokinetic properties of Vimentin-IN-1 in mice [1]

Route Dose (mg/kg) AUC 0-last (ng·h/mL) AUC 0-inf (ng·h/mL) T 1/2 (h) T max (h) T last (h) C max (ng/mL)
4e PO 10 371.33 534.33 4.68 0.67 8 154.67
4e IP 1 208.33 211.33 0.59 0.25 4 197.00
Five1 PO 25 309.78 339.21 4.57 0.5 18 110.43

MCE has not independently confirmed the accuracy of these methods. They are for reference only.


Appearance

Solid


Shipping

Room temperature in continental US; may vary elsewhere.


Storage

Powder -20°C 3 years
4°C 2 years
In solvent -80°C 6 months
-20°C 1 month

Solvent & Solubility

In Vitro:

DMSO : 25 mg/mL ( 64.22 mM ; Need ultrasonic)

Preparing
Stock Solutions
Concentration Solvent Mass 1 mg 5 mg 10 mg
1 mM 2.5688 mL 12.8442 mL 25.6885 mL
5 mM 0.5138 mL 2.5688 mL 5.1377 mL
10 mM 0.2569 mL 1.2844 mL 2.5688 mL
* Please refer to the solubility information to select the appropriate solvent.
In Vivo:
  • 1.

    Add each solvent one by one: 10% DMSO >> 40% PEG300 >> 5% Tween-80 >> 45% saline

    Solubility: 2.5 mg/mL (6.42 mM); Suspended solution; Need ultrasonic

* All of the co-solvents are available by MCE.